(Q48949780)

17 February 2018

reason for preferred rank

title

The substance P(1–7) fragment is a potent modulator of substance P actions in the brain (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

1 November 2022

The substance P(1-7) fragment is a potent modulator of substance P actions in the brain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698511

1 November 2022

0 references

Herrera-Marschitz M

1

1 reference

17 February 2018

M. Herrera-Marschitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698511

1 November 2022

L. Terenius

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698511

1 November 2022

T. Sakurada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698511

1 November 2022

M. S. Reid

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698511

1 November 2022

U. Ungerstedt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698511

1 November 2022

language of work or name

English

0 references

publication date

1 June 1990

1 reference

17 February 2018

25 June 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1698511

full work available at URL

1 November 2022

https://api.elsevier.com/content/article/PII:000689939091558X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

https://api.elsevier.com/content/article/PII:000689939091558X?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

1 November 2022

1 reference

17 February 2018

volume

521

1 reference

17 February 2018

issue

1-2

1 reference

17 February 2018

page(s)

316-320

1 reference

17 February 2018

Effects of a nonapeptide FTS on lymphocyte differentiations in vitro

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Vasoactive intestinal peptide and electrical activity influence neuronal survival

1 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Binding of flexible ligands to macromolecules

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Effects of intranigral application of dopamine and substance P on the in vivo release of newly synthesized [(3)H]-dopamine in the ipsilateral caudate nucleus of the cat

1 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Dual Actions of Substance P on Nociception: Possible Role of Endogenous Opioids

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Presence of substance P and GABA in separate striatonigral neurons

1 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Substance P and behavior: Opposite effects of N-terminal and C-terminal fragments

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Evidence that striatal efferents relate to different dopamine receptors

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Projections of substance P containing neurons from neostriatum to substantia nigra.

1 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Catecholamine uptake processes

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Substance P infusion into substantia nigra of the rat: Behavioural analysis and ionvolvemetn of striatal dopamine

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Modulation of cat monosynaptic reflexes by substance P

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Rotatory behavior in rats by intranigral application of substance P and an eledoisin fragment

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.

1 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Measurement of substance P metabolites in rat CNS.

1 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

β-Endorphin stimulates corticosterone synthesis in isolated rat adrenal cells

1 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Beta-endorphin-(1-27) antagonizes beta-endorphin- but not morphine-, D-Pen2-D-Pen5-enkephalin- and U50, 488H-induced analgesia in mice

1 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)91558-X

1 November 2022

Identifiers

1 reference

17 February 2018

1 reference

17 February 2018